Quantifying Human Health Risks from Animal Antimicrobials

References

• American Hospital Association (AHA)Hospital Statistics (2001) . Health Forum, American Hospital Association, Chicago, ILGoogle Scholar
• Angulo F. J., Nargund V. N., Chiller T. C. Evidence of an association between use of anti-microbial agents in food animals and anti-microbial resistance among bacteria isolated from humans and the human health consequences of such resistance. J. Vet Med. B Infectious Disease Vet. Public Health (2004) 51(8–9):374–379Crossref, Google Scholar
• Austin D. J., Bonten M. J. M., Weinstein R. A., Slaughter S., Anderson R. M. Vancomycin-resistant enterococci in intensive-care hospital settings: Transmission dynamics, persistence, and the impact of infection control programs. Proc. National Acad. Sci. USA (1999) 96:6908–6913Crossref, Google Scholar
• Bafundo K. What to expect from the inclusion or deletion of growth promoting antibiotics in animal feeds: Effects in animals and in man. (2004) . Animal Feed Manufacturers Association (AFMA) Forum, March 10–12, Sun City, Northwest Province, South Africa. http://www.afma.co.za/AFMA_Template/feedpaper2.htmlGoogle Scholar
• Bafundo K., Cox L. A. Human health risk from use of virginiamycin in chickens. (2002) Presented at 37th National Meeting on Poultry Health and ProcessingOct. 9–11Ocean City, MD http://www.poultryegg.org/SPSS/vacc/fullscreen.htm. Summarized in The Poultry Informed Professional, Vol. 67, Department of Avian Medicine, University of Georgia, Athens, GA. http://www.avian.uga.edu/documents/pip/2002/1102.pdfGoogle Scholar
• Barza M., Travers K. Excess infections due to antimicrobial resistance: The “attributable fraction. Clinical Infectious Diseases (2002) 34(Suppl. 3):S126–S130Crossref, Google Scholar
• Buzby J. C., Roberts T., Lin C. T. Jordan, MacDonald J. M. Bacterial foodborne disease: Medical costs and productivity losses. (1996) . US Department of Agriculture, Economic Research Service, Agricultural Economics, Report # 741. http://www.ers.usda.gov/publications/aer741/Google Scholar
• Casewell M., Friis C., Marco E., McMullin P., Phillips I. The European ban on growth-promoting antibiotics and emerging consequences for human and animal health. J. Antimicrobial Chemotherapy (2003) 52(2):159–161Crossref, Google Scholar
• Centers for Disease Control and Prevention (CDC) Preliminary FoodNet data on the incidence of infection with pathogens transmitted commonly through food—10 sites, United States. 2004. Morbidity Mortality Weekly Report (2005) 54(14):352–356Google Scholar
• Cervantes H. Assessing the results of the EU ban on antibiotic feed additives. (2005) . ThePigSite.com, feature article. http://www.thepigsite.com/FeaturedArticle/Default.asp?Display=1509Google Scholar
• Clark N. C., Cooksey R. C., Hill B. C., Swenson J. M., Tenover F. C. Characterization of glycopeptide-resistant enterococci from U.S. hospitals. J. Antimicrobial Agents Chemotherapy (1993) 37(11):2311–2317Crossref, Google Scholar
• Cox L. A. Reexamining the causes of campylobacteriosis. Internat. J. Infectious Diseases (2002) 6(Suppl. 3):S26–S36Crossref, Google Scholar
• Cox L. A. Potential human health benefits of antibiotics used in food animals: A case study of virginiamycin. Environment Internat. (2005) 31(4):549–563Crossref, Google Scholar
• Cox L. A.Quantitative Health Risk Analysis Methods: Modeling the Human Health Impacts of Antibiotics Used in Food Animals (2006) (Springer, New York) Google Scholar
• Cox L. A., Popken D. A. A simulation model of human health risks from chicken-borne Campylobacter jejuni. Technology (2002) 9(1–2):55–84Google Scholar
• Cox L. A., Popken D. A. Bayesian Monte Carlo uncertainty analysis of human health risks from animal antimicrobial use in a dynamic model of emerging resistance. Risk Anal. (2004a) 24(5):1153–1164Crossref, Google Scholar
• Cox L. A., Popken D. A. Quantifying human health risks from virginiamycin used in chickens. Risk Anal. (2004b) 24(1):271–288Crossref, Google Scholar
• Cox L. A., Popken D. A. Quantifying potential human health impacts of animal antibiotic use: Enrofloxacin and macrolides in chickens. Risk Anal. (2006) 26(1):135–146Crossref, Google Scholar
• Cox L. A., Babayev D., Huber W. Some limitations of qualitative risk rating systems. Risk Anal. (2005) 25(3):651–662Crossref, Google Scholar
• Critchley I. A., Blosser-Middleton R. S., Jones M. E., Thornsberry C., Sahm D. F., Karlowsky J. A. Baseline study to determine in vitro activities of daptomycin against gram-positive pathogens isolated in the United States in 2000–2001. Antimicrobial Agents Chemotherapy (2003) 47(5):1689–1693Crossref, Google Scholar
• Cromwell G. L. Why and how antibiotics are used in swine production. Animal Biotechnology (2002) 13(1):7–27Crossref, Google Scholar
• Cummings T. S. Stakeholder position paper: Poultry. Prev Vet. Med. (2006) 73(2–3):209–212Crossref, Google Scholar
• Danish Integrated Antimicrobial Resistance Monitoring and Research Programme (DANMAP) (2004) . Use of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from food animals, foods and humans in Denmark. http://www.dfvf.dk/default.asp?ID=9604Google Scholar
• Danish Zoonosecenter (2001) . Annual reports on Zoonoses in Denmark 1997–2000. http://zoonyt.dzc.dkGoogle Scholar
• ElAmin A. Foodborne Campylobacter infections increase. (2006) . Foodproductiondaily.com. Retrieved January 3, 2006. http://www.foodproductiondaily.com/news/ng.asp?id=64828Google Scholar
• Eliopoulos G. M., Wennersten C. B., Gold H. S., Schulin T., Soull M., Farris M. G., Cerwinka S., Nadler H. L., Dowzicky M., Talbot G. H., Moellering R. C. Characterization of vancomycin resistant enteroccocus faecium isolates from the United States and their susceptibility in-vitro to dalfopristin-quinupristin. Antimicrobial Agents Chemotherapy (1998) 42(5):1088–1092Crossref, Google Scholar
• European Food Safety Authority (EFSA) (2006) . Trends and sources of zoonoses, zoonotic agents and antimicrobial resistance in the European Union in 2004. http://www.efsa.europa.eu/en/publications/scientific.htmlGoogle Scholar
• European Union (EU) (2000) . Communication from the Commission on the Precautionary Principle. Report COM (2000) 1, Commission of the European Communities, Brussels, Belgium, 2/2/2000. http://ec.europa.eu/comm/dgs/health_consumer/library/pub/pub07_en.pdfGoogle Scholar
• Eurosurveillance Campylobacteriosis in Norway 2001: Incidence still rising. Eurosurveillance Weekly (2002) 6(24). http://www.eurosurveillance.org/ew/2002/020613.aspGoogle Scholar
• Eurosurveillance Trends in zoonoses in Europe 2003. Eurosurveillance Weekly (2005) 10(5):26 http://www.eurosurveillance.org/ew/2005/050526.aspGoogle Scholar
• Harder B. Put out to pasture: Strategy to prolong antibiotics’ potency. Sci. News (2002) 161(17). http://www.keepantibioticsworking.com/new/news.cfm?RefID=36667Crossref, Google Scholar
• Hayes D. J., Jensen H. H. Lessons from the Danish ban on feed-grade antibiotics. Choices Magazine (2003) third quarter). http://www.choicesmagazine.org/2003-3/2003-3-01.pdfGoogle Scholar
• Hershberger E., Oprea S. F., Donabedian S. M., Perri M., Bozigar P., Bartlett P., Zervos M. J. Epidemiology of antimicrobial resistance in enterococci of animal origin. J. Antimicrobial Chemotherapy (2005) 55(1):127–130Crossref, Google Scholar
• Hurd H. S. Can antibiotic use in food animals actually reduce consumer risk? Food Safety Asia (2005) 2:120–122 http://www.gdspublishing.com/ic_pdf/fsa/phib.pdfGoogle Scholar
• Institute for Agriculture and Trade Policy (IATP) FDA: Use of virginiamycin in animals no significant threat to human health. Ag Observatory (2004) Dec. 27). http://www.agobservatory.org/headlines.cfm?refID=37706Google Scholar
• Jones R. N., Fritsche T. R., Sader H. S., Goldstein B. P. Antimicrobial spectrum and potency of dalbavancin tested against clinical isolates from Europe and North America (2003): Initial results from an international surveillance protocol. J. Chemotherapy (2005) 17(6):593–600Crossref, Google Scholar
• Jones R. N., Sader H. S., Erwin M. E., Anderson S. A.Enterococcus Study Group Emerging multiply resistant enterococci among clinical isolates. I. Prevalence data from 97 medical center surveillance study in the United States. Diagnostic Microbiology Infectious Disease (1995) 21(2):85–93Crossref, Google Scholar
• Jones R. N., Ballow C. H., Acar J., Fluit A., Sader H. S., Turnidge J., Deinhart J., Biedenbach D. J. World-wide evaluation of quinupristin/qalfopristin (Q/D; Synercid) antimicrobial activity directed against resistant gram-positive pathogens: Report from global SMART study. 39th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) (1999) San Francisco, CA http://www.ket-on-line.com/icaac/Posters/Jones.pdfGoogle Scholar
• KeepMedia World-leading pork exporter Denmark sees sharp increase in pig mortality. (2005) . www.keepmedia.com/ShowItemDetails.do?itemID=991278&extID=10030Google Scholar
• Lawton R. M., Fridkin S. K., Gaynes R. P., McGowan J. E. Practices to improve antimicrobial use at 47 US hospitals: The status of the 1997 SHEA/IDSA position paper recommendations. Infection Control and Hospital Epidemiology (2000) 21(4):256–259Crossref, Google Scholar
• Linden P. K. Treatment options for vancomycin-resistant enterococcal infections. Drugs (2002) 62(3):425–441Crossref, Google Scholar
• Linden P. K., Pasculle A. W., McDevitt D., Kramer D. J. Effect of quinupristin/dalfopristin on the outcome of vancomycin-resistant Enterococcus faecium bacteraemia: Comparison with a control cohort. J. Antimicrobial Chemotherapy (1997) 39(Suppl. A):145–151Crossref, Google Scholar
• Marano N., Vugia D., Fiorentino T., Segler S., Carter M., Kassenborg H., Smith K., Sansky S., Hollinger K., Angulo F., EIP FoodNet Working Group . Fluoroquinolone-resistant Campylobacter causes longer duration of diarrhea than fluoroquinolone-susceptible Campylobacter strains in FoodNet sites. International Conference on Emerging Infectious Diseases (2000) Atlanta, GASynopsis www.cdc.gov/foodnet/pub/publications/2000/marano_2000.pdfGoogle Scholar
• McDermott P. F., Zhao S., Wagner D. D., Simjee S., Walker R. D., White D. G. The food safety perspective of antibiotic resistance. Animal Biotechnology (2002) 13(1):71–84Crossref, Google Scholar
• Moellering R. C., Linden P. K., Reinhardt J., Blumberg E. A., Bompart F., Talbot G. H. The efficacy and safety of quinupristin-dalfopristin for the treatment of infections caused by vancomycin-resistant Enterococcus faecium. J. Antimicrobial Chemotherapy (1999) 44(2):251–261Crossref, Google Scholar
• National Academies of Science (NAS)The Use of Drugs in Food Animals: Benefits and Risks (1999) (National Academies Press, Washington, D.C.) Google Scholar
• National Nosocomial Infections Surveillance (NNIS)Amer. J. Infection Control (2001) 29:404–421National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992–June 2001, issued August 2001Google Scholar
• National Research Council The use of drugs in food animals: Benefits and risks. (1998) . National Research Council and the Institute of Medicine Report, National Research Council, Washington, D.C.Google Scholar
• Patrick M. E., Christiansen L. E., Waino M., Ethelberg S., Madsen H., Wegener H. C. Effects of climate on incidence of Campylobacter spp. in humans and prevalence in broiler flocks in Denmark. Appl. Environmental Microbiology (2004) 70(12):74–80Crossref, Google Scholar
• Pugh D. M. The EU precautionary bans of animal feed additive antibiotics. Toxicology Letters (2002) 128(1–3):35–44Crossref, Google Scholar
• Russell S. M. The effect of airsacculitis on bird weights, uniformity, fecal contamination, processing errors, and populations of Campylobacter spp. and escherichia coli. Poultry Sci. (2003) 82(8):1326–1331Crossref, Google Scholar
• Samuel M. C., Vugia D. J., Shallow S., Marcus R., Segler S., McGivern T., Kassenborg H., Reilly K., Kennedy M., Angulo F., Tauxe R. V., Emerging Infections Program FoodNet Working Group . Epidemiology of sporadic Campylobacter infection in the United States and declining trend in incidence, FoodNet 1996–1999. Clinical Infectious Diseases (2004) 38(Suppl. 3):S165–S174Crossref, Google Scholar
• Shnayerson M., Plotkin M. J.The Killers Within: The Deadly Rise of Drug-Resistant Bacteria (2002) (Little, Brown and Company, Boston, MA) Google Scholar
• Shryock T. (2003) . Antibiotic resistance: A global perspective. Paper presented at American Meat Institute trade show, Nashville, TN. www.meatami.com/Content/TradeShow/ConferenceMaterials/2004Mirc/Tom%20Shryock.pdfGoogle Scholar
• Snary E. L., Kelly L. A., Davison H. C., Teale C. J., Wooldridge M. Antimicrobial resistance: A microbial risk assessment perspective. J. Antimicrobial Chemotherapy (2004) 53(6):906–917Crossref, Google Scholar
• State of New Jersey (SNJ) Epidemiology surveillance system 1998 report. (2000) . New Jersey Department of Health and Senior Services, Division of Epidemiology, Environmental and Occupational Health. http://www.state.nj.us/health/cd/ess1998Google Scholar
• Stern N. J., Robach M. C. Enumeration of Campylobacter spp. in broiler feces and in corresponding processed carcasses. J. Food Protection (2003) 66(9):1557–1563Crossref, Google Scholar
• Swann M. M. (1969) . Report of the Joint Committee on the Use of Antibiotics in Animal Husbandry and Veterinary Medicine, Her Majesty’s Stationary Office, London, UKGoogle Scholar
• Thal L. A., Donabedian S., Robinson-Dunn B., Chow J. W., Dembry L., Clewell D. B., Alshab D., Zervos M. J. Molecular analysis of glycopeptide-resistant enterococcus faecium isolates collected from Michigan hospitals over a 6-year period. J. Clinical Microbiology (1998) 36(11):3303–3308Google Scholar
• US Food and Drug Administration, Center for Veterinary Medicine (FDA-CVM) Draft risk assessment of streptogramin resistance in enterococcus faecium attributable to the use of streptogramins in animals. (2004) . November 23. Rockville, MDGoogle Scholar
• Webb M., Riley L. W., Roberts R. B. Cost of hospitalization for and risk factors associated with vancomycin resistant Enterococcus faecium infection and colonization. Clinical Infectious Diseases (2001) 33(4):445–452Crossref, Google Scholar
• Wegener H. C. Antibiotics in animal feed and their role in resistance development. Curr. Opin. Microbiol (2003) 6(5):439–445Crossref, Google Scholar
• Willems R. J., Homan W., Top J., van Santen-Verheuvel M., Tribe D., Manzioros X., Gaillard C., Vandenbroucke-Grauls C. M., Mascini E. M., van Kregten E., van Embden J. D., Bonten M. J. Variant esp gene as a marker of a distinct genetic lineage of vancomycin-resistant enterococcus faecium spreading in hospitals. Lancet (2001) 357(9259):853–855Crossref, Google Scholar
• Willems R. J. L., Top J., van den Braak N., van Belkum A., Endtz H., Mevius D., Stobberingh E., van den Bogaard A., van Embden J. D. A. Host specificity of vancomycin-resistant enterococcus faecium. J. Infectious Diseases (2000) 182(3):816–823Crossref, Google Scholar
• World Health Organization (WHO) Joint FAO/OIE/WHO Expert Workshop on Non-Human Antimicrobial Usage and Antimicrobial Resistance: Scientific Assessment. (2003a) . Geneva, Switzerland, December 1–5. http://www.who.ints/foodsafety/publications/micro/en/amr.pdfGoogle Scholar
• World Health Organization (WHO) Background document for the joint WHO/FAO/OIE Expert Workshop on Non-Human Antimicrobial Usage and Antimicrobial Resistance: Scientific Assessment. (2003b) . Geneva, Switzerland, Dec. 1–5. http://www.who.int/foodsafety/publications/micro/en/background.pdfGoogle Scholar